Tandem Diabetes Care TNDM reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Tandem Diabetes Care missed estimated earnings by 1300.0%, reporting an EPS of $-0.24 versus an estimate of $0.02.
Revenue was up $28.12 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.16 which was followed by a 15.05% drop in the share price the next day.
Here's a look at Tandem Diabetes Care's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.07 | 0.21 | 0.06 | -0.08 |
EPS Actual | -0.23 | 0.16 | 0.09 | 0.06 |
Revenue Estimate | 168.43M | 199.12M | 171.41M | 143.63M |
Revenue Actual | 175.91M | 210.00M | 179.63M | 172.14M |
To track all earnings releases for Tandem Diabetes Care visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.